CLASS II Device recall · Reported 31 Jul 2019 · FDA Enforcement Report

Smart Disclosure System recalled by Spacelabs Healthcare

Spacelabs Healthcare is recalling Smart Disclosure System, distributed nationwide in the US. The recall was initiated on 28 Jan 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll affected Smart Disclosure installations with software versions 5.00, 5.01, 5.02, or 5.03, UDI 10841522123580.
Quantity recalled295 customer sites have the affected software versions

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2035-2019
FDA event ID
83220
Recalling firm
Spacelabs Healthcare, Snoqualmie, WA
Classification
Class II
Status
Terminated
Recall initiated
28 Jan 2019
FDA classified
22 Jul 2019
Reported
31 Jul 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

28 Jan 2019Recall initiated by company
22 Jul 2019Classified by FDA+175 days
31 Jul 2019Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Several reports were received that patient records were printed with the correct patient demographics but containing another patient's waveforms.

Product as listed by the FDA

Spacelabs Healthcare Smart Disclosure System, Model 92810, a component of the Intesys Clinical Suite (ICS) G2.

Where it was distributed

Distribution was nationwide. There was also government and military distribution. Foreign distribution was made to Argentina, Bahrain, Bolivia, Brazil, Canada, Cayman Islands, Chile, China, Costa Rica, Czech Republic, France, Hong Kong, India, Indonesia, Italy, Kuwait, Malaysia, Mexico, Netherlands, Pakistan, Palestine, Panama, Philippines, Poland, Qatar, Romania, Saudi Arabia, Spain, Switzerland, Taiwan, Trinidad and Tobago, Tunisia, Turkey, UAE, United Kingdom, and Viet Nam.

Nationwide

Questions about this recall

Why was it recalled?

Several reports were received that patient records were printed with the correct patient demographics but containing another patient's waveforms.

Which lots are affected?

All affected Smart Disclosure installations with software versions 5.00, 5.01, 5.02, or 5.03, UDI 10841522123580.

Where was it sold?

Distribution was nationwide. There was also government and military distribution. Foreign distribution was made to Argentina, Bahrain, Bolivia, Brazil, Canada, Cayman Islands, Chile, China, Costa Rica, Czech Republic, France, Hong Kong, India, Indonesia, Italy, Kuwait, Malaysia, Mexico, Netherlands, Pakistan, Palestine, Panama, Philippines, Poland, Qatar, Romania, Saudi Arabia, Spain, Switzerland, Taiwan, Trinidad and Tobago, Tunisia, Turkey, UAE, United Kingdom, and Viet Nam.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Spacelabs Healthcare

All 47

Other Other Medical Devices recalls

All 13,908